Have a feature idea you'd love to see implemented?
Let us know!
AURA Aura Biosciences Inc
Price (delayed)
$11.5
Market cap
$570.47M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.79
Enterprise value
$559.43M
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet
Highlights
Aura Biosciences's EPS has increased by 11% YoY and by 3.8% QoQ
AURA's debt is down by 7% YoY
AURA's equity is up by 15% year-on-year but it is down by 8% since the previous quarter
The company's net income fell by 18% YoY and by 2.6% QoQ
AURA's quick ratio is down by 15% from the previous quarter and by 2.5% YoY
Key stats
What are the main financial stats of AURA
Market
Valuations
Earnings
Shares outstanding
49.61M
Market cap
$570.47M
Enterprise value
$559.43M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.98
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$80.5M
EBITDA
-$77.34M
Free cash flow
-$74.39M
Per share
Balance sheet
Liquidity
EPS
-$1.79
Free cash flow per share
-$1.5
Book value per share
$3.86
Revenue per share
$0
TBVPS
$4.41
Total assets
$218.28M
Total liabilities
$26.83M
Debt
$19.03M
Equity
$191.45M
Working capital
$185.05M
Debt to equity
0.1
Current ratio
18.54
Quick ratio
17.77
Net debt/EBITDA
0.14
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-36.3%
Return on equity
-41.5%
Return on invested capital
-41.8%
Return on capital employed
-38.8%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AURA stock price
How has the Aura Biosciences stock price performed over time
Intraday
-1.29%
1 week
16.63%
1 month
20.17%
1 year
36.9%
YTD
29.8%
QTD
29.07%
Financial performance
How have Aura Biosciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$90.35M
Net income
-$80.69M
Gross margin
N/A
Net margin
N/A
AURA's operating income is down by 23% year-on-year and by 2.8% since the previous quarter
The company's net income fell by 18% YoY and by 2.6% QoQ
Growth
What is Aura Biosciences's growth rate over time
Valuation
What is Aura Biosciences stock price valuation
P/E
N/A
P/B
2.98
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Aura Biosciences's EPS has increased by 11% YoY and by 3.8% QoQ
AURA's price to book (P/B) is 58% more than its last 4 quarters average of 1.9
AURA's equity is up by 15% year-on-year but it is down by 8% since the previous quarter
Efficiency
How efficient is Aura Biosciences business performance
AURA's return on invested capital is up by 17% year-on-year and by 2.8% since the previous quarter
Dividends
What is AURA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AURA.
Financial health
How did Aura Biosciences financials performed over time
AURA's current ratio is down by 16% since the previous quarter
AURA's quick ratio is down by 15% from the previous quarter and by 2.5% YoY
AURA's debt is 90% less than its equity
The debt to equity has declined by 17% year-on-year but it is up by 11% since the previous quarter
AURA's equity is up by 15% year-on-year but it is down by 8% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.